Biosynex (ALBIO) — Cash Flow Quality Index
Biosynex (ALBIO) has a Cash Flow Quality Index of 0.19x as of June 2022. Operating cash flow of €5.96 Million is below net income of €30.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Biosynex long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biosynex Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Biosynex across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Biosynex tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Biosynex (2017–2022)
Year-by-year earnings quality comparison for Biosynex. For live market cap and the full company financial profile, see Biosynex (ALBIO) market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.32x | €4.95 Million | €15.61 Million | ▼ -69.2% |
| 2021 | 1.03x | €109.83 Million | €106.68 Million | ▲ +2.1% |
| 2020 | 1.01x | €31.64 Million | €31.37 Million | ▼ -53.2% |
| 2019 | 2.15x | €1.10 Million | €512.31K | ▲ +150.5% |
| 2018 | 0.86x | €467.12K | €542.89K | ▼ -44.1% |
| 2017 | 1.54x | €484.82K | €315.22K | — |